Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024)

Smith & Nephew (SNN) reported Depreciation & Amortization (CF) of $273.0 million for Q4 2024, down 4.55% on a YoY basis from $286.0 million in Q1 2024, and down 4.55% quarter-over-quarter from $286.0 million in Q4 2023.

Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Depreciation & Amortization (CF) for 15 years, with the latest figure at $273.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Depreciation & Amortization (CF) fell 4.55% year-over-year to $273.0 million; the trailing twelve-month figure through Dec 2025 stood at $273.0 million (down 68.55% YoY), and the FY2025 full-year result was $239.0 million, down 62.95% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2024 stood at $273.0 million, down from $286.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $309.0 million in Q4 2022, with the low at $271.0 million in Q4 2020.
  • Historically, Depreciation & Amortization (CF) has averaged $286.6 million across 5 years, with a median of $286.0 million in 2023.
  • Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) slumped 47.68% — and 2021, when it increased 8.49%.
  • Smith & Nephew's Depreciation & Amortization (CF) stood at $271.0 million in 2020, then increased by 8.49% to $294.0 million in 2021, then rose by 5.1% to $309.0 million in 2022, then slipped by 7.44% to $286.0 million in 2023, then decreased by 4.55% to $273.0 million in 2024.
  • The last three Depreciation & Amortization (CF) figures came in at $273.0 million (Q4 2024), $286.0 million (Q4 2023), and $309.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 381.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 120.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 749.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 40.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 67.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 78.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 123.40 Mn
10 Smith & Nephew 5.27 Bn 4.69 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 273.00 Mn
Dec 31, 2024 273.00 Mn
Dec 31, 2023 286.00 Mn
Dec 31, 2023 286.00 Mn
Dec 31, 2022 309.00 Mn
Dec 31, 2022 309.00 Mn
Dec 31, 2021 294.00 Mn
Dec 31, 2021 294.00 Mn
Dec 31, 2020 271.00 Mn
Dec 31, 2020 271.00 Mn
Dec 31, 2019 518.00 Mn
Dec 31, 2019 518.00 Mn
Dec 31, 2018 454.00 Mn
Dec 31, 2018 454.00 Mn
Dec 31, 2017 460.00 Mn
Dec 31, 2017 460.00 Mn
Dec 31, 2016 478.00 Mn
Dec 31, 2016 478.00 Mn
Dec 31, 2015 511.00 Mn
Dec 31, 2015 511.00 Mn